Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentino Conter

Showing results (71-80 of 131) with videos related to

Pageof 14
Sort By:
Leukemia|December 12, 2022
Invasive fungal diseases impact on outcome of childhood ALL - an analysis of the international trial AIEOP-BFM ALL 2009Thomas Lehrnbecher, Andreas H Groll, Simone Cesaro, et al.
Pharmacogenomics|September 8, 2018
Genetic risk factors for VIPN in childhood acute lymphoblastic leukemia patients identified using whole-exome sequencingRachid Abaji, Francesco Ceppi, Swati Patel, et al.
Leukemia Research|June 6, 2013
Linking genomic lesions with minimal residual disease improves prognostic stratification in children with T-cell acute lymphoblastic leukaemiaRoberta La Starza, Antonella Lettieri, Valentina Pierini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2010
Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005Maurizio Aricò, Martin Schrappe, Stephen P Hunger, et al.
Haematologica|September 15, 2018
Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: high white blood cell count at diagnosis is the strongest prognostic factorAndrea Biondi, Gunnar Cario, Paola De Lorenzo, et al.
The Journal of Pediatrics|October 6, 2022
Development and Initial Validation of the ONCOREUM Score to Differentiate Childhood Cancer with Arthropathy from Juvenile Idiopathic ArthritisAdele Civino, Francesca Bovis, Marta Ponzano, et al.
Haematologica|December 10, 2020
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemiaAlaeddin Khalil, Gudrun Würthwein, Jana Golitsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2008
Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapyMaurizio Aricò, Maria Grazia Valsecchi, Carmelo Rizzari, et al.
Haematologica|October 12, 2014
Clinical features and outcome of SIL/TAL1-positive T-cell acute lymphoblastic leukemia in children and adolescents: a 10-year experience of the AIEOP groupMariella D'Angiò, Maria G Valsecchi, Anna M Testi, et al.
Hemasphere|June 5, 2023
Incidence and Characteristics of Hypersensitivity Reactions to PEG-asparaginase Observed in 6136 Children With Acute Lymphoblastic Leukemia Enrolled in the AIEOP-BFM ALL 2009 Study ProtocolCarmelo Rizzari, Anja Möricke, Maria Grazia Valsecchi, et al.
Pageof 14

Showing results (71-80 of 131) with videos related to

Sort By:
Pageof 14
Leukemia|December 12, 2022
Invasive fungal diseases impact on outcome of childhood ALL - an analysis of the international trial AIEOP-BFM ALL 2009Thomas Lehrnbecher, Andreas H Groll, Simone Cesaro, et al.
Pharmacogenomics|September 8, 2018
Genetic risk factors for VIPN in childhood acute lymphoblastic leukemia patients identified using whole-exome sequencingRachid Abaji, Francesco Ceppi, Swati Patel, et al.
Leukemia Research|June 6, 2013
Linking genomic lesions with minimal residual disease improves prognostic stratification in children with T-cell acute lymphoblastic leukaemiaRoberta La Starza, Antonella Lettieri, Valentina Pierini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2010
Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005Maurizio Aricò, Martin Schrappe, Stephen P Hunger, et al.
Haematologica|September 15, 2018
Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: high white blood cell count at diagnosis is the strongest prognostic factorAndrea Biondi, Gunnar Cario, Paola De Lorenzo, et al.
The Journal of Pediatrics|October 6, 2022
Development and Initial Validation of the ONCOREUM Score to Differentiate Childhood Cancer with Arthropathy from Juvenile Idiopathic ArthritisAdele Civino, Francesca Bovis, Marta Ponzano, et al.
Haematologica|December 10, 2020
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemiaAlaeddin Khalil, Gudrun Würthwein, Jana Golitsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2008
Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapyMaurizio Aricò, Maria Grazia Valsecchi, Carmelo Rizzari, et al.
Haematologica|October 12, 2014
Clinical features and outcome of SIL/TAL1-positive T-cell acute lymphoblastic leukemia in children and adolescents: a 10-year experience of the AIEOP groupMariella D'Angiò, Maria G Valsecchi, Anna M Testi, et al.
Hemasphere|June 5, 2023
Incidence and Characteristics of Hypersensitivity Reactions to PEG-asparaginase Observed in 6136 Children With Acute Lymphoblastic Leukemia Enrolled in the AIEOP-BFM ALL 2009 Study ProtocolCarmelo Rizzari, Anja Möricke, Maria Grazia Valsecchi, et al.
Pageof 14